Presentations

2012 Annual Meeting

This activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Edication through the joint sponsorship of the University of Vermont and the American Society for Experimental NeuroTherapeutics. The University of Vermont is accredited by the ACCME to provide continuing medical education for physicians

At the completion of the meeting participants will be able to

  • Describe new FDA guidance on clinical trial outcome measures
  • Outline the role of neuroinflammation in brain disease
  • Discuss the issues relating to the proper conduct of clinical trials with internation aspects, including pharmacoepidemiology and regulatory consideration

more

2011 Annual Meeting

This activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Edication through the joint sponsorship of the University of Vermont and the American Society for Experimental NeuroTherapeutics. The University of Vermont is accredited by the ACCME to provide continuing medical education for physicians

At the completion of the meeting participants will be able to

  • Describe new FDA guidance on clinical trial outcome measures
  • Outline the role of neuroinflammation in brain disease
  • Discuss the issues relating to the proper conduct of clinical trials with internation aspects, including pharmacoepidemiology and regulatory consideration

more

2010 Annual Meeting

Presentations from ASENT's  12th Annual Meeting :

  • Challenges in Conducting Drug Trials
  • Post Marketing Trials
  • Drug Development Challenges
  • Pipeline Presentations
  • Spectrum of Mitochondrial Dysfunction
  • Comparative Effectiveness

more

2009 Annual Meeting

Presentations from the ASENT 11th Annual Meeting:

  • Methodological Issues in Examining Cognition Across CNS Disorders
  • Methodological Issues in Traumatic Brain Injury Research
  • Methodological Issues and Translation Research in Traumatic Brain Injury
  • Resource Allocation in Translation Neuroscience: Perspectives on Influencing the Pipeline
  • Pharmacogenetics: Implications for CNS Drug Development in the 21st Century
  • Pipeline Projects
  • The Role of Neuroimaging in Clinical Trials and Drug Discovery
  • Clinical Trials in Neurotherapeutics

more

2008 Annual Meeting

Presentations from the ASENT 10th Annual Meeting: 

  • 7th Advocacy Forum
  • Clinical Trials Class (Morning and Afternoon)
  • Friday and Saturday Morning Symposia
  • Friday Afternoon General Session

more

2007 Annual Meeting

Presentations from the ASENT 9th Annual Meeting: 

  • Intellectual Property & Therapeutics Development
  • Fundamentals of Clinical Trials in Neurotherapeutics
  • Ion Channels as Targets for Neurotherapeutics Development
  • Disease Specific Clinical Trial Think Tanks
  • Neuroethics
  • Neurologic Therapeutics in Pediatrics
  • Sleep and Neurotherapeutics

more

2006 Annual Meeting Presentations

ASENT's 8th Annual Meeting more

2005 Annual Meeting Highlights

ASENT's 7th Annual Meeting Highlights more

2004 Annual Meeting Highlights

Translational Neurotherapeutics ASENT's 6th Annual Meeting more

2003 Annual Meeting

ASENT 5th Annual Meeting - Highlights more

2002 Speaker Abstracts

ASENT's 4th Annual Meeting Speaker Abstracts more